Neuphoria Therapeutics
Price & Volume
Stats
See more52W Range | $3.64-$21.40 |
Market Cap | $24.2M |
Shares Short | 19,598 |
Financials
See moreRevenue (12 Mos) | -$13,267 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$13,267 |
Diluted EPS | -$7.90 |
News
See moreYahoo Finance • 6 months ago
Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions
Yahoo Finance • 6 months ago
Neuphoria Therapeutics Inc. Sends Letter to Stockholders
Yahoo Finance • 7 months ago
Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process
About
CEO | Dr. Spyridon Papapetropoulos M.D., Ph.D. |
Address | 100 Summit Drive, Burlington, MA, United States, 01803 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 7 |